Jean-Pierre Routy

Professor

McGill University Health Centre

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Immunology Immunology professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jean-Pierre Routy is a Professor at McGill University Health Centre in Canada. His research primarily focuses on the intersection of HIV and metabolic disorders, exploring areas such as gut microbiota, viral dynamics, and immune response in HIV-infected populations. Recent publications highlight his investigations into bone cell differentiation, treatment interruptions, and the implications of social determinants on HIV therapy outcomes.

Articles (23)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (14)

Mark Brockman

Associate Professor and Canada Research Chair (II)

Simon Fraser University

CANADA

View details

Giada Sebastiani

CANADA

View details

Betsy Barnes

Professor

Hofstra University North Shore Long Island Jewish School of Medicine

UNITED STATES

View details

Mohammad-Ali Jenabian

Université de Montréal

CANADA

View details

Marco Constante

McMaster University

CANADA

View details

Guy Cloutier

CANADA

View details

Cecilia T. Costiniuk

CANADA

View details

Zabrina Brumme

Associate Professor

Simon Fraser University

CANADA

View details

Daniel Elias Kaufmann

Chief, Division of Infectious Diseases

Lausanne University Hospital

SWITZERLAND

View details

Petronela Ancuta

Professor of Immunology

faculty of medicine university of montréal montréal canada

CANADA

View details

David Olagnier

Associate Professor (with tenure)

Aarhus University

DENMARK

View details

Louis-Patrick Haraoui

Université de Sherbrooke

CANADA

View details

Nicole F. Bernard

CANADA

View details

Bertrand Lebouché

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jean-Pierre Routy

Research Interests

Explore related searches

Contact this professor

About

Articles (23)

Distinct Gut Microbiota Signatures Are Associated with Severity of Metabolic Dysfunction-Associated Steatotic Liver Disease in People with HIV

Opposite Roles of IL-32α Versus IL-32β/γ Isoforms in Promoting Monocyte-Derived Osteoblast/Osteoclast Differentiation and Vascular Calcification in People with HIV

Early Viral Dynamics Predict Human Immunodeficiency Virus Posttreatment Control After Analytic Treatment Interruption

Correlates of Breakthrough SARS-CoV-2 Infections in People with HIV: Results from the CIHR CTN 328 Study

Phylogenetic Network Analyses Reveal the Influence of Transmission Clustering on the Spread of HIV Drug Resistance in Quebec from 2002 to 2022

Feasibility of a Randomized, Interventional Pilot Clinical Study of Oral Cannabinoids in People with HIV on Antiretroviral Therapy: CTNPT 028

IL-32 Drives the Differentiation of Cardiotropic CD4+ T Cells Carrying HIV DNA in People With HIV

Impact of social determinants of health on time to antiretroviral therapy initiation and HIV viral undetectability for migrants enrolled in a multidisciplinary HIV clinic with rapid, free, and onsite B/F/TAF: ‘The ASAP study’

Alterations in Th17 Cells and Non-Classical Monocytes as a Signature of Subclinical Coronary Artery Atherosclerosis during ART-Treated HIV-1 Infection

Double-Negative T-Cells during Acute Human Immunodeficiency Virus and Simian Immunodeficiency Virus Infections and Following Early Antiretroviral Therapy Initiation

Application of metagenomic next-generation sequencing with brain tissue biopsy for diagnosing intracranial lesions in people with HIV

The TLR7/IRF-5 axis sensitizes memory CD4+ T cells to Fas-mediated apoptosis during HIV-1 infection

Harnessing Autophagy to Overcome Antigen-Specific T-Cell Dysfunction: Implication for People Living with HIV-1

Switch to a raltegravir‐based antiretroviral regimen in people with HIV and non‐alcoholic fatty liver disease: A randomized controlled trial

Doravirine responses to HIV-1 viruses bearing mutations to NRTIs and NNRTIs under in vitro selective drug pressure

Control of porphyria cutanea tarda with anti-IL-17 secukinumab in a person with psoriasis living with HIV

Effects of Oral Cannabinoids on Systemic Inflammation and Viral Reservoir Markers in People with HIV on Antiretroviral Therapy: Results of the CTN PT028 Pilot Clinical Trial

Differential Impact of IL-32 Isoforms on the Functions of Coronary Artery Endothelial Cells: A Potential Link with Arterial Stiffness and Atherosclerosis

Phenotypic characterization of single CD4+ T cells harboring genetically intact and inducible HIV genomes

The Frequency and Function of NKG2C+CD57+ Adaptive NK Cells in Cytomagalovirus Co-Infected People Living with HIV Decline with Duration of Antiretroviral Therapy

Excess BAFF May Impact HIV-1-Specific Antibodies and May Promote Polyclonal Responses Including Those from First-Line Marginal Zone B-Cell Populations

The Influence of Oral Terbinafine on Gut Fungal Microbiome Composition and Microbial Translocation in People Living with HIV Treated for Onychomycosis

Subclinical Atherosclerosis Is Associated with Discrepancies in BAFF and APRIL Levels and Altered Breg Potential of Precursor-like Marginal Zone B-Cells in Long-Term HIV Treated Individuals

Collaborators (14)

Mark Brockman

Giada Sebastiani

Betsy Barnes

Mohammad-Ali Jenabian

Marco Constante

Guy Cloutier

Cecilia T. Costiniuk

Zabrina Brumme

Daniel Elias Kaufmann

Petronela Ancuta

David Olagnier

Louis-Patrick Haraoui

Nicole F. Bernard

Bertrand Lebouché

Make your next move.